124 related articles for article (PubMed ID: 1314177)
1. Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.
Araujo FG; Lin T; Remington JS
Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):71-3. PubMed ID: 1314177
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ
Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
[TBL] [Abstract][Full Text] [Related]
3. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
Araujo FG; Lin T; Remington JS
J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
[TBL] [Abstract][Full Text] [Related]
4. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis.
Araujo FG; Remington JS
Antimicrob Agents Chemother; 1991 Aug; 35(8):1672-3. PubMed ID: 1656872
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.
Araujo FG; Prokocimer P; Remington JS
J Infect Dis; 1992 Apr; 165(4):788. PubMed ID: 1532409
[No Abstract] [Full Text] [Related]
8. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.
Araujo FG; Guptill DR; Remington JS
Antimicrob Agents Chemother; 1988 May; 32(5):755-7. PubMed ID: 2840017
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM
Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of atovaquone alone or in combination with azithromycin against acute murine toxoplasmosis.
Moshkani SK; Dalimi A
Vet Res Commun; 2000 Apr; 24(3):169-77. PubMed ID: 10836275
[TBL] [Abstract][Full Text] [Related]
11. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
Araujo FG; Shepard RM; Remington JS
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
[TBL] [Abstract][Full Text] [Related]
12. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
Khan AA; Lambert LH; Remington JS; Araujo FG
Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
[TBL] [Abstract][Full Text] [Related]
13. Rifabutin is active in murine models of toxoplasmosis.
Araujo FG; Slifer T; Remington JS
Antimicrob Agents Chemother; 1994 Mar; 38(3):570-5. PubMed ID: 8203856
[TBL] [Abstract][Full Text] [Related]
14. Minocycline in the chemotherapy of murine toxoplasmosis.
Tabbara KF; Sakuragi S; O'Connor GR
Parasitology; 1982 Apr; 84(Pt 2):297-302. PubMed ID: 7070843
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
Lopes CD; Silva NM; Ferro EA; Sousa RA; Firminot ML; Bernardes ES; Roque-Barreira MC; Pena JD
J Parasitol; 2009 Aug; 95(4):1005-10. PubMed ID: 20050006
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
18. Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.
Harper JS; London WT; Sever JL
Am J Trop Med Hyg; 1985 Jan; 34(1):50-7. PubMed ID: 3970309
[TBL] [Abstract][Full Text] [Related]
19. Use of ketolides in combination with other drugs to treat experimental toxoplasmosis.
Araujo FG; Khan AA; Bryskier A; Remington JS
J Antimicrob Chemother; 1998 Nov; 42(5):665-7. PubMed ID: 9848454
[TBL] [Abstract][Full Text] [Related]
20. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
